Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duofluorid XII is a dual-fluoride topical dental varnish developed and manufactured by the Brazilian dental company FGM. It is distinguished by its combination of two different fluoride sources: sodium fluoride (NaF) and calcium fluoride (CaF2), providing a total fluoride concentration of approximately 6% (or 5.63% depending on source calibration). The formulation is designed for a dual-action release profile where sodium fluoride provides a rapid release of fluoride ions for immediate remineralization and relief from dentinal hypersensitivity, while calcium fluoride remains on the tooth surface as a pH-dependent reservoir. This reservoir releases fluoride over a prolonged period when the oral environment becomes acidic, offering sustained protection. It is primarily indicated for the prevention of dental caries, the remineralization of incipient white spot lesions, and the treatment of cervical dentinal hypersensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Duofluorid XII.